FGF21 gene therapy as treatment for obesity and insulin resistance

Veronica Jimenez1,2,3, Claudia Jambrina1,2,3, Estefania Casana1,2,3

  • 1Center of Animal Biotechnology and Gene Therapy (CBATEG), Universitat Autònoma de Barcelona, Bellaterra, Spain.

Insights

Gene therapy using fibroblast growth factor 21 (FGF21) offers a potential long-term treatment for obesity and type 2 diabetes (T2D). This approach successfully reduced body weight and improved metabolic health in animal models.

Area of Science:

  • Metabolic diseases
  • Gene therapy
  • Endocrinology

Background:

  • Rising global prevalence of type 2 diabetes (T2D) and obesity necessitates novel therapeutic strategies.
  • Existing treatments for T2D and obesity are not universally effective due to population heterogeneity.
  • Fibroblast growth factor 21 (FGF21) shows therapeutic promise, but native forms have poor pharmacokinetics.

Purpose of the Study:

  • To evaluate the efficacy of FGF21 gene therapy for treating T2D and obesity.
  • To assess the long-term metabolic benefits and safety of sustained FGF21 production.
  • To explore FGF21's potential in preventing age-related metabolic decline.

Main Methods:

  • Adeno-associated viral vectors (AAV) were employed for FGF21 gene delivery to liver, adipose, or skeletal muscle.
  • Animal models, including those on high-fat diets and ob/ob mice, were utilized.
  • Metabolic parameters, body weight, and tissue health were monitored over extended periods.

Main Results:

  • Sustained FGF21 secretion via gene therapy led to significant reductions in body weight and adipose tissue hypertrophy/inflammation.
  • Improvements were observed in hepatic steatosis, inflammation, fibrosis, and insulin resistance lasting over a year.
  • FGF21 gene therapy prevented weight gain and insulin resistance in healthy animals during aging, with no observed side effects.

Conclusions:

  • FGF21 gene therapy represents a promising strategy for durable treatment of obesity and T2D.
  • This approach effectively addresses multiple facets of metabolic dysfunction.
  • Gene therapy offers a viable alternative to overcome the pharmacokinetic limitations of native FGF21.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
633
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.0K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K